Segment Reporting - Schedule of Operating Financial Results of Reportable Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting Information, Profit (Loss) [Abstract] | ||||||
| Revenue | $ 18,940 | $ 12,083 | $ 35,056 | $ 22,272 | ||
| Less: | ||||||
| Cost of sales | 4,398 | 3,214 | 8,089 | 5,767 | ||
| Selling expenses | 9,157 | 6,028 | 17,042 | 11,042 | ||
| Marketing expenses | 1,173 | 840 | 2,663 | 1,772 | ||
| Product and software development costs | 3,576 | 2,171 | 6,652 | 3,651 | ||
| Clinical, medical, and regulatory expenses | 1,358 | 1,167 | 2,705 | 2,188 | ||
| Other segment expenses | 10,314 | 5,165 | 18,217 | 10,073 | ||
| Interest expense | 313 | 363 | 624 | 720 | ||
| Interest income | (839) | (336) | (1,730) | (716) | ||
| Change in fair value of warrant liabilities | 0 | 237 | 0 | 270 | ||
| Net loss | $ (10,510) | $ (8,696) | $ (6,766) | $ (5,729) | $ (19,206) | $ (12,495) |
| X | ||||||||||
- Definition Clinical, medical, and regulatory expenses. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|